A next wave of cancer treatments may combine immunotherapy and gene editing.
How a controversial Chinese cloning company burnishes its credentials with a prize.
Doctors at the University of Pennsylvania seek approval for gene editing to fight cancer.
The brain’s built-in protection system also prevents potentially lifesaving drugs from getting in, but maybe not for much longer.
To match cancer patients with drugs, one company plans to offer free genetic tests.
If you would like to update the frequency or type of newsletters received, please edit your newsletter preferences or unsubscribe from all MIT Technology Review communications.MIT Technology ReviewOne Main StreetCambridge, MA 02142
